Bayer takes on German biotech Direvo
Bayer Healthcare has bolstered its biologics drive after acquired German biotech company Direvo Biotech for €210 million.
Read MoreAuthor: Katrina Megget
NHS energy bill expected to skyrocket causing concerns
NHS health trusts are feeling the pinch of skyrocketing energy bills, fuelling fears hospital services may be cut to plug the finance gaps, an investigation has found.
Read MoreTask force launched to address medicines for children
A special Paediatric Task Force has been created to improve availability of medicines and vaccines for children.
Read MoreFDA concerned with deaths linked to Pfizer’s bone drug
Pfizer’s shares dropped more than 2% yesterday after US regulators cited concerns over the drug giant’s osteoporosis drug Fablyn (lasofoxifene).
Read MoreMerck Serono gets in on Ablynx’s nanobodies
Merck Serono has joined forces with biopharmaceutical company Ablynx in a deal that could be worth more than 335 million euro to co-develop therapeutic proteins for two targets in oncology and immunology.
Read More- Ipsen announces new data on Dysport in neurological disease
- PMGroup Worldwide Ltd welcomes MAD World Summit
- Argenx receives review from FDA for VYVGART in seronegative gMG
- Nuclera extends Series C funding to advance antibody engineering
- Cellistic launches new iPSC-based platforms to expand immuno-oncology therapies
